Nonpenetrating glaucoma surgery: A critical evaluation

Current Opinion in Ophthalmology

Volumn 18, Issue 2, 2007, Pages 152-158

  Sarodia, Usman ^a   Shaarawy, Tarek ^b   Barton, Keith ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Glaucoma filtration surgery; Goniopuncture; Nonpenetrating glaucoma surgery; Trabeculectomy

Indexed keywords

MITOMYCIN C;

CATARACT EXTRACTION; COMPARATIVE STUDY; EYE BIOPSY; GLAUCOMA SURGERY; HUMAN; IMPLANT; INTRAOCULAR PRESSURE; PRIORITY JOURNAL; REVIEW; SCLERECTOMY; SURGICAL TECHNIQUE; TRABECULECTOMY; VISCOCANALOSTOMY;

CELL PROLIFERATION; FILTERING SURGERY; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; TRABECULAR MESHWORK; TREATMENT OUTCOME;

EID: 33847040404     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e328091c1ae     Document Type: Review

References (55)

1. Cairns JE. Trabeculectomy: preliminary report of a new method. Am J Ophthalmol 1968; 66:673-679.
2. Watson P. Trabeculectomy: a modified ab externo technique. Ann Ophthalmol 1970; 2:199-205.
3. El Sayyad F, Helal M, El-Kholify H, et al. Nonpenetrating deep sclerectomy versus trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology 2000; 107:1671-1674.
4. Chiselita D. Nonpenetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery. Eye 2001; 15:197-201.
5. Cillino S, Di Pace F, Casuccio A, et al. Deep sclerectomy versus punch trabeculectomy with and without phacoemulsification: a randomised clinical trial. J Glaucoma 2004; 13:500-506.
6. Yarangumeli A, Gureser S, Gurbuz Koz O, et al. Viscocanalostomy versus trabeculectomy in patients with bilateral high-tension glaucoma. Int Ophthalmol 2004; 25:207-213.
7. Yalvac IS, Sahin M, Eksioglu U, et al. Primary viscocanalostomy versus trabeculectomy for primary open-angle glaucoma: three-year prospective randomised clinical trial. J Cataract Refract Surg 2004; 30:2050-2057.
8. O'Brart DPS, Rowlands E, Islam N, Noury AMS. A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 2002; 86:748-754.
9. O'Brart DPS, Shiew M, Edmunds B. A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 2004; 88:1012-1017.
10. Luke C, Dietlein TS, Jacobi PC, et al. A prospective randomised trial of viscocanalostomy versus trabeculectomy in open-angle glaucoma: a 1-year follow-up study. J Glaucoma 2002; 11:294-299.
11. Carassa RG, Bettin P, Fiori M, Brancato R. Viscocanalostomy versus trabeculectomy in whit adults affected by open-angle glaucoma: a 2-year randomised controlled trial. Ophthalmology 2003; 110:882-887.
12. Kobayashi H, Kobayashi K, Okinami S. A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open angle glaucoma. Graefe's Arch Clin Exp Ophthalmol 2003; 241:359-366.
13. Ambresin A, Shaarawy T, Mermoud A. Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma 2002; 11:214-220.
14. Shaarawy T, Mansouri K, Schnyder C, et al. Long-term results of deep sclerectomy with collagen implant. J Cataract Refract Surg 2004; 30:1225-1231.
15. Khairy HA, Green FD, Nassar MK, Azuara-Blanco A. Control of intraocular pressure after deep sclerectomy. Eye 2006; 20:336-340. This study illustrates poor long-term IOP control following initial success after deep sclerectomy. Only 5% of patients underwent goniopuncture and wider use may have enhanced success.
16. Mansouri K, Shaarawy T, Wedrich A, Mermoud A. Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomised controlled trial. J Glaucoma 2006; 15:264-270. This randomised study compared a collagen implant with a low-cost alternative PMMA implant and found equal rates of success in the two groups. Cheaper implants would substantially reduce the cost of NPGS.
17. Jungkim S, Gibran SK, Khan K, Murray A. External trabeculectomy with T-flux implant. Eur J Ophthalmol 2006; 16:416-421. Ab-externo trabeculectomy combined with the T-flux implant produced significant IOP reduction with few complications though mean IOP tended to increase over time.
18. Shaarawy T, Mermoud A. Deep sclerectomy in one eye vs deep sclerectomy with collagen implant in the contralateral eye of the same patient: long-term follow-up. Eye 2005; 19:298-302.
19. Khairy HA, Atta HR, Green FD, et al. Ultrasound biomicroscopy in deep sclerectomy. Eye 2005; 19:555-560.
20. Demailly P, Lavat P, Kretz G, Jeanteur-Lunel MN. Nonpenetrating deep sclerectomy (NPDS) with or without collagen device (CD) in primary open-angle glaucoma: middle-term retrospective study. Int Ophthalmol 1996; 20:131-140.
21. Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN, et al. Nonpenetrating deep sclerectomy: a 6-year retrospective study. Eur J Ophthalmol 2004; 14:26-36.
22. Wevill MT, Meyer D, Van Aswegen E. A pilot study of deep sclerectomy with implantation of chromic suture material as a collagen implant: medium-term results. Eye 2005; 19:549-554.
23. Devloo S, Deghislage C, Van Malderen L, et al. Nonpenetrating deep sclerectomy without or with autologous scleral implant in open-angle glaucoma: medium-term results. Graefe's Arch Clin Exp Ophthalmol 2005; 243:1206-1212.
24. Hamard P, Lachkar Y. Non penetrating filtering surgery, evolution and results. J Fr Ophthalmol 2002; 225:527-536.
25. Kozobolis VP, Christodoulakis EV, Tzanakis N, et al. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open angle glaucoma. J Glaucoma 2002; 11:287-293.
26. Neudorfer M, Sadetzki S, Anisimova S, Geyer O. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C. Ophthalmic Surg Lasers Imaging 2004; 35:6-12.
27. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005; 19:442-450.
28. Mielke C, Dawda VK, Anand N. Deep sclerectomy and low dose mitomycin C: a randomised prospective trial in West Africa. Br J Ophthalmol 2006; 90:310-313. Deep sclerectomy did not control IOP in the majority of these high-risk patients despite use of MMC. The inability to perform goniopuncture illustrates its importance so integral to success of deep sclerectomy.
29. Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 1999; 25:316-322.
30. Sunaric-Megevand G, Leuenberger P. Results of viscocanalostomy for primary open-angle glaucoma. Am J Ophthalmol 2001; 132:221-228.
31. Stangos AN, Whatham AR, Sunaric-Megevand G. Primary viscocanalostomy for juvenile open-angle glaucoma. Am J Ophthalmol 2005; 140:490-496.
32. Luke C, Dietlein TS, Jacobi PC, et al. A prospective randomised trial of viscocanalostomy with and without implantation of a reticulated hyaluronic acid implant (SKGEL) in open angle glaucoma. Br J Ophthalmol 2003; 87:599-603.
33. Yarangumeli A, Gurboz Koz O, Alp MN, et al. Viscocanalostomy with mitomycin-C: a preliminary study. Eur J Ophthalmol 2005; 15:202-208.
34. Mermoud A, Schnyder CC, Sickenberg M, et al. Comparison of deep sclerectomy with collagen implant and trabeculectomy in open-angle glaucoma. J Cataract Refract Surg 1999; 25:323-331.
35. Watson PG, Jakeman C, Ozturk M, et al. The complications of trabeculectomy (a 20-year follow-up). Eye 1990; 4:425-438.
36. Molteno ACB, Bosma NJ, Kittelson JM. Otago glaucoma surgery outcome study: long-term results of trabeculectomy: 1976 to 1995. Ophthalmology 1999; 106:1742-1750.
37. Jonescu-Cuypers CP, Jacobi PC, Konen W, Krieglstein GK. Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: a randomised clinical trial. Ophthalmology 2001; 108:254-258.
38. Moreno-Lopez M, Perez-Alvarez MJ. Short- and medium-term intraocular pressure lowering effects of combined phacoemulsification and nonpenetrating deep sclerectomy without scleral implant or antifibrotics. Arch Soc Esp Oftalmol 2006; 81:93-100. Cataract surgery combined with deep sclerectomy is demonstrated to be safe. This technique allows rapid visual recovery and significant lowering of IOP.
39. Wishart PK, Wishart MS, Porooshani H. Viscocanalostomy and deep sclerectomy for the surgical treatment of glaucoma: a long-term follow-up. Acta Ophthalmol Scand 2003; 81:343-348.
40. Funnell CL, Clowes M, Anand N. Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy. Br J Ophthalmol 2005; 89:694-698.
41. Gianoli F, Schnyder CC, Bovey E, Mermoud A. Combined surgery for cataract and glaucoma: phacoemulsification and deep sclerectomy compared with phacoemulsification and trabeculectomy. J Cataract Refract Surg 1999; 25:340-346.
42. Rebolleda G, Munoz-Negrete FJ. Comparison between phaco-deep sclerectomy converted into phaco-trabeculectomy and uneventful phaco-deep sclerectomy. Eur J Ophthalmol 2005; 15:343-346.
43. Chiou AGY, Mermoud A, Jewelewicz DA. Postoperative inflammation following deep sclerectomy with collagen implant versus standard trabeculectomy. Graefe's Arch Clin Exp Ophthalmol 1998; 236:593-596.
44. Egrilmez S, Ates H, Nalcaci S, et al. Surgically induced corneal refractive change following glaucoma surgery: nonpenetrating trabecular surgeries versus trabeculectomy. J Cataract Refract Surg 2004; 30:1232-1239.
45. Corcostegui J, Rebolleda G, Munoz-Negrete FJ. Refractive changes after phacoemulsification combined with deep sclerectomy assisted by corneal topography. J Cataract Refract Surg 2004; 30:2391-2396.
46. Bauchiero L, Demarie A, Belli L, Brogliatti B. Deep sclerectomy and viscocanalostomy: critical revision of the results obtained during the learning curve. Acta Ophthalmol Scand 2002; 236 (Suppl):64-66.
47. Sanchez E, Schnyder CC, Mermoud A. Comparative results of deep sclerectomy transformed to trabeculectomy and classical trabeculectomy. Klin Monatsbl Augenheilkd 1997; 210:261-264.
48. Dietlein TS, Jacobi PC, Luke C, Krieglstein G. Morphological variability of the trabecular meshwork in glaucoma patients: implications for nonperforating glaucoma surgery. Br J Ophthalmol 2000; 84:1354-1359.
49. Mermoud A, Karlen M-E, Schnyder CC, et al. Nd:YAG goniopuncture after deep sclerectomy with collagen implant. Ophthalmic Surg Lasers 1999; 30:120-125.
50. Vuori M-L. Complications of neodymium:YAG laser goniopuncture after deep sclerectomy. Acta Ophthalmol Scand 2003; 81:573-576.
51. Kim CY, Hong YJ, Seong GJ, et al. Iris synechia after laser goniopuncture in a patient having deep sclerectomy with a collagen implant. J Cataract Refract Surg 2002; 28:900-902.
52. Ainsworth JR, Jay JL. Cost analysis of early trabeculectomy versus conventional management in primary open angle glaucoma. Eye 1991; 5:322-328.
53. Bateman DN, Clark R, Azuaro Blanco A, et al. The effects of new topical treatments on the management of glaucoma in Scotland: an examination of ophthalmological healthcare. Br J Ophthalmol 2002; 86:551-554.
54. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120:1268-1279.
55. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130:429-440.